ACE - inhibitors and AT1R - antagonists are the first line medication for IgA nephropathy

Abstract

IgA nephropathy is the most common primary glomerulonephritis. Urinalysis usually reveals predominant hematuria, in half of patients macroscopic.

Chronic renal failure develops in 40% patients within 20 years from diagnosis.

Keywords

• IgA nephropathy
• ACE inhibitors
• AT1R blockers